Company Filing History:
2 out of 10 
1 out of 1 
1 out of 832,891 Years Active: 2011-2023
Title: Ebrahim Versi: Innovator in Opioid Treatment
Introduction
Ebrahim Versi is a notable inventor based in Gladstone, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of drug addiction. With a total of 4 patents to his name, Versi's work focuses on innovative methods to address critical health issues.
Latest Patents
One of Ebrahim Versi's latest patents involves a method for treating drug addiction and reducing dependence on opiate drugs. This invention comprises administering a compound with a specific structure, which has the IUPAC name of (−)3-((S)-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)(3-thienyl)methyl)phenol, or its pharmaceutically acceptable esters or salts. The compound is designed to act on the mu, delta, and kappa opioid receptors, providing added analgesia with an improved therapeutic index and a reduced risk of respiratory depression.
Career Highlights
Ebrahim Versi has worked with various companies throughout his career, including Versi Group, LLC. His innovative approach and dedication to improving drug treatment options have positioned him as a key figure in the pharmaceutical industry.
Collaborations
One of his notable collaborators is Bruce Reidenberg, with whom he has worked on various projects aimed at advancing opioid treatment methodologies.
Conclusion
Ebrahim Versi's contributions to the field of drug addiction treatment through his innovative patents highlight his commitment to improving healthcare solutions. His work continues to influence the pharmaceutical landscape, making a significant impact on the lives of those struggling with addiction.